Zelluna (OSE: ZLNA), a company pioneering allogeneic 'off-the-shelf' T Cell Receptor-based Natural Killer (TCR-NK) cell ...

Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, toda ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...

Experts at NIMHANS conference urge integration of engineering, technology, and brain sciences to enhance cognitive neuroscience research.

No one has had a Synchron brain-computer interface longer than Rodney Gorham. He’s still finding new ways to use it.

Strikes by NHS workers at Queen's Hospital in Romford that will affect blood test results and other services begin today.

More than 10,000 Americans are waiting for a liver transplant. Many more never make the list, because they are too sick to ...

Connected medical devices improve patient care but introduce severe cybersecurity risks that require stringent regulatory ...

Closing of additional $50 million tranche of $100 million equity private placement after achievement of clinical milestone ...

Focused ultrasound technology may allow medications to pass through the blood brain barrier to treat tumors in the brain ...

IT ops is like a silent engine; it’s not just about fixing servers, but about building trust so people can do their jobs ...